Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bioasis Technologies Inc. BIOAF


Primary Symbol: V.BTI

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.


TSXV:BTI - Post by User

Post by InitiumMMXXIIIon Nov 16, 2023 4:47pm
197 Views
Post# 35740070

Some Reality Therapy

Some Reality TherapyWith this post I am introducing my new Stockhouse alias, "InitiumMMXXIII". (Latin for "start 2023". It had to be something.) My previous alias was "Boomskid." At my request, SH retired that alias on Monday afternoon, November 13, 2023.

I wasn't going to get a new alias until some future date but this mornng there was news in our family that relates to the BBB and the treatment of brain tumours.

Three weeks ago or so, my wife's grandniece (granddaughter of her sister), suddenly became ill. Symptoms were confusing but within a day she was diagnosed with a brain tumour. She is 16 years old and had never had any health issues until this event.

She was operated on within 4 or 5 days of the first diagnosis. Word finally came through today that the tumour was glioblastoma, untreatable, and that she has days, perhaps weeks of time left to her. 

Bioasis was created over 15 years ago to do something about this type of thing. One of the reasons I remained so passionate about the possibilities of xB3 was the possibility that it could effectively enable the treatment of a host of brain disorders of this sort.

For many years I wanted so badly to scream at Bioasis to get on with it, to do something. In the end, only Mark Day made an attempt at real preclinical work in support of future human clinical trials.

I'm not going to rehash it all here and now, but as this young girl's life ebbs away, and I watch the pain my wife and her family will be enduring for a long time, I will be thinking of Bioasis, and what could have been, and should have been, if xB3 works as we have been hoping for so, so, long.

jd
<< Previous
Bullboard Posts
Next >>